GI Practice

Coordinating Care with Functional Medicine and Nutrition Without Duplicating Work

April 22, 20267 min readBy GLP1Gut Team
Reviewed by {{REVIEWER_PLACEHOLDER}}
SIBOcare coordinationfunctional medicinemultidisciplinaryGI practice

📋TL;DR: Many SIBO patients see both a gastroenterologist and a functional medicine practitioner or nutritionist, often without either provider knowing the full picture. This leads to duplicated testing, conflicting supplement and medication regimens, and confused patients. Establishing clear role delineation, shared treatment goals, and a communication protocol reduces wasted effort and improves patient outcomes. The GI provider's role in this coordination is to own the medical diagnosis and pharmacological management while supporting the complementary work of other providers.

The patient pulls out a bag of 12 supplements, a restrictive diet plan from their naturopath, and tells you they are also doing antimicrobial herbs "just in case" while waiting for your rifaximin prescription. This is not an unusual scenario. Most SIBO patients are working with multiple providers, and most of those providers are not talking to each other. This creates clinical noise that makes management harder for everyone.

How Common Is Multi-Provider SIBO Care?

Very common. A survey of SIBO patients in online communities found that over 60 percent were simultaneously seeing a gastroenterologist and at least one complementary provider (naturopath, functional medicine doctor, or nutritionist). Only 15 percent reported that their providers communicated directly with each other.

This pattern emerges partly because conventional GI and functional medicine address different aspects of SIBO management. GIs handle diagnosis, prescription medications, and monitoring. Functional practitioners often focus on dietary therapy, supplement protocols, and lifestyle modifications. The patient needs both, but the lack of coordination creates gaps and conflicts.

What Are the Most Common Coordination Failures in Multi-Provider SIBO Care?

  • Duplicated breath testing ordered by both providers at different intervals
  • Conflicting dietary recommendations (one restricting, one expanding)
  • Herb-drug interactions between prescribed medications and supplement protocols
  • Contradictory messages about treatment expectations and timelines
  • Patient receiving antimicrobial herbs concurrently with prescription antibiotics without either provider knowing
  • Supplement protocols that interfere with breath test preparation

How Should GI Providers Approach Patients Who See Functional Medicine Practitioners?

With curiosity rather than dismissal. Many GI providers have reflexive skepticism toward functional medicine, and some of it is warranted. But dismissing the functional practitioner dismisses the patient, who likely feels that provider has helped them in ways conventional medicine did not.

A productive approach is to ask what the other provider has recommended and why. "Tell me about the supplements you are taking and what they are for." This gives you the information you need to assess for interactions and conflicts without positioning yourself as the opponent of their other care.

If there are genuine safety concerns (significant herb-drug interactions, dangerous dietary restriction, unproven testing driving inappropriate treatment), address them clearly and directly. If the complementary interventions are benign and not interfering with your management, acknowledge them and focus on your scope.

What Role Delineation Works Best for SIBO Multi-Provider Teams?

The clearest delineation separates medical management from nutritional and lifestyle management. The GI provider owns: diagnosis (including breath testing), prescription medications (antibiotics, prokinetics), red flag screening, and monitoring for complications. The complementary provider manages: dietary therapy, supplement protocols (with the GI's awareness), stress management, and lifestyle modifications.

This delineation should be communicated explicitly to the patient. "Dr. Smith is managing your diet and supplements. I am managing your medications and making sure nothing else is going on. We are working on the same problem from different angles." Patients who understand the structure are less likely to get confused by different recommendations.

How Do You Establish Communication with Non-Conventional Providers?

A brief fax or secure message establishing the shared patient and your treatment plan is usually sufficient. Most functional medicine providers welcome communication from the GI and will share their protocol if asked. Keep it clinical and focused: current diagnosis, medications, testing plan, and any concerns about interactions.

If direct provider-to-provider communication is not practical, having the patient serve as the communication conduit works if you give them specific information to relay. A printed after-visit summary listing your current plan and any concerns about concurrent treatments is a low-tech but effective approach.

When Should GI Providers Push Back on Complementary Recommendations?

Push back when there is a safety concern, not a philosophical disagreement. Berberine supplements at standard doses alongside rifaximin are probably fine. A recommendation to stop all pharmaceuticals and rely solely on herbal antimicrobials is a clinical judgment call. Unnecessary testing that drives unwarranted treatment (comprehensive stool panels leading to aggressive protocols) is worth addressing.

Frame your concerns in terms of patient safety and evidence, not disciplinary politics. "I am concerned about taking oregano oil at this dose while on rifaximin because we do not have interaction data" is more effective than "Your naturopath does not know what they are doing."

What Helps

A shared data source reduces information asymmetry between providers. Tools like GLP1Gut give the patient a symptom record they can share with all their providers, creating a common reference point for treatment decisions regardless of which provider is reviewing the data.

Key Takeaways

  • Over 60 percent of SIBO patients see multiple providers, but direct provider communication occurs in fewer than 15 percent of cases
  • Clear role delineation (medical vs. nutritional/lifestyle) reduces conflicting recommendations and patient confusion
  • Approach complementary providers with curiosity rather than dismissal to maintain the patient relationship
  • Push back on safety concerns with evidence-based reasoning, not disciplinary bias

Should GI providers recommend specific functional medicine practitioners for SIBO patients?

If you know practitioners in your area who practice evidence-based functional or integrative medicine, referrals can be valuable. This ensures the patient gets complementary care from someone whose approach aligns with yours. If you do not have trusted referral relationships, being honest about that while supporting the patient's choice is appropriate.

Are herbal antimicrobials as effective as rifaximin for SIBO?

A 2014 study by Chedid et al. found comparable normalization rates between herbal antimicrobials and rifaximin. However, the study was small and not blinded. The evidence is not strong enough to recommend herbals as first-line over rifaximin, but it does suggest they may be a reasonable alternative for patients who cannot access or tolerate prescription antibiotics.

How do you handle supplement protocols that you think are unnecessary?

If the supplements are not harmful or interacting with medications, it may not be worth the relationship cost of insisting they stop. If the supplements are expensive and unsupported, share that perspective while respecting the patient's autonomy. If there is a genuine safety or interaction concern, be direct and specific about why the supplement needs to be paused or stopped.

Sources & References

  1. 1.Herbal therapy is equivalent to rifaximin for SIBO - Chedid V, et al., Global Advances in Health and Medicine (2014)
  2. 2.Integrative approaches to SIBO: survey of patient practices - Rezaie A, et al., Digestive Diseases and Sciences (2020)
  3. 3.ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth - Pimentel M, et al., American Journal of Gastroenterology (2020)
  4. 4.Herb-drug interactions in gastroenterology practice - Posadzki P, et al., World Journal of Gastroenterology (2013)
  5. 5.Multidisciplinary care models in chronic GI conditions - Keefer L, et al., Gastroenterology (2021)

Medical Review: {{REVIEWER_PLACEHOLDER}}

Medical Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice and should not replace clinical judgment. Always apply your own professional assessment when making treatment decisions.

Send to a Patient

Your Next Follow-Up Could Start with Actual Data

Instead of 'I think the bloating was a little better,' your patient walks in with two weeks of timestamped meals, bloat scores, and a trigger list. Pick the easiest way to send them the app.

Email

Pre-written message

Text

SMS with link

WhatsApp

Pre-filled message